Literature DB >> 7538480

DNA base modifications and antioxidant enzyme activities in human benign prostatic hyperplasia.

R Olinski1, T H Zastawny, M Foksinski, A Barecki, M Dizdaroglu.   

Abstract

The authors have studied DNA base damage and activities of antioxidant enzymes in human benign prostatic hyperplasia (BPH) tissues and surrounding disease-free tissues removed from prostate glands of 15 patients. In these tissues, endogenous levels of various typical hydroxyl radical-induced products of DNA bases and activities of catalase and superoxide dismutase were measured. The majority of patients had higher levels of DNA base lesions and lower activities of enzymes in BPH tissues than in normal prostate tissues. When activities of both enzymes were lower in BPH tissues than in normal tissues, the increases in the amounts of DNA base lesions over control levels were most prominent. In the case of similar enzyme activities in both BPH and normal tissues, no changes in levels of DNA base lesions were observed. These results suggest a possible association between antioxidant enzyme activities and levels of DNA base lesions in BPH tissues. Some of the identified DNA lesions are known to be premutagenic and may play a role in carcinogenesis. Although a possible link between BPH and prostate cancer is controversial, BPH patients with both decreased antioxidant enzyme activities and increased levels of DNA lesions may be at risk of developing prostate cancer.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7538480     DOI: 10.1016/0891-5849(94)00171-f

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  12 in total

1.  Endogenous oxidative DNA base modifications analysed with repair enzymes and GC/MS technique.

Authors:  P Jaruga; E Speina; D Gackowski; B Tudek; R Olinski
Journal:  Nucleic Acids Res       Date:  2000-03-15       Impact factor: 16.971

Review 2.  Epithelial cell senescence: an adaptive response to pre-carcinogenic stresses?

Authors:  Corinne Abbadie; Olivier Pluquet; Albin Pourtier
Journal:  Cell Mol Life Sci       Date:  2017-07-13       Impact factor: 9.261

Review 3.  Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer.

Authors:  H Wiseman; B Halliwell
Journal:  Biochem J       Date:  1996-01-01       Impact factor: 3.857

Review 4.  Cancer risk and oxidative DNA damage in man.

Authors:  S Loft; H E Poulsen
Journal:  J Mol Med (Berl)       Date:  1996-06       Impact factor: 4.599

5.  Models of DNA structure achieve almost perfect discrimination between normal prostate, benign prostatic hyperplasia (BPH), and adenocarcinoma and have a high potential for predicting BPH and prostate cancer.

Authors:  D C Malins; N L Polissar; S J Gunselman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-07       Impact factor: 11.205

Review 6.  The Role of Heat Shock Protein 70 Subfamily in the Hyperplastic Prostate: From Molecular Mechanisms to Therapeutic Opportunities.

Authors:  Xun Fu; Huan Liu; Jiang Liu; Michael E DiSanto; Xinhua Zhang
Journal:  Cells       Date:  2022-06-28       Impact factor: 7.666

7.  The senescence-associated secretory phenotype promotes benign prostatic hyperplasia.

Authors:  Paz Vital; Patricia Castro; Susan Tsang; Michael Ittmann
Journal:  Am J Pathol       Date:  2014-01-13       Impact factor: 4.307

8.  Oxidative stress promotes benign prostatic hyperplasia.

Authors:  Paz Vital; Patricia Castro; Michael Ittmann
Journal:  Prostate       Date:  2015-09-29       Impact factor: 4.104

9.  Increased susceptibility of chronic ulcerative colitis-induced carcinoma development in DNA repair enzyme Ogg1 deficient mice.

Authors:  Jie Liao; Darren N Seril; Gary G Lu; Meng Zhang; Shinya Toyokuni; Allison L Yang; Guang-Yu Yang
Journal:  Mol Carcinog       Date:  2008-08       Impact factor: 4.784

10.  Stimulation of Prostate Cells by the Senescence Phenotype of Epithelial and Stromal Cells: Implication for Benign Prostate Hyperplasia.

Authors:  Shoulei Jiang; Chung Seog Song; Bandana Chatterjee
Journal:  FASEB Bioadv       Date:  2019-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.